Free Trial

Chill Brands Group (CHLL) Competitors

Chill Brands Group logo

CHLL vs. PXS, MXC, RGT, CEL, N4P, HELD, BXP, HLN, HIK, and HCM

Should you be buying Chill Brands Group stock or one of its competitors? The main competitors of Chill Brands Group include Provexis (PXS), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), N4 Pharma (N4P), Hellenic Dynamics (HELD), Beximco Pharmaceuticals (BXP), Haleon (HLN), Hikma Pharmaceuticals (HIK), and HUTCHMED (HCM). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Chill Brands Group vs. Its Competitors

Chill Brands Group (LON:CHLL) and Provexis (LON:PXS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

0.2% of Chill Brands Group shares are owned by institutional investors. Comparatively, 7.9% of Provexis shares are owned by institutional investors. 24.2% of Chill Brands Group shares are owned by company insiders. Comparatively, 21.6% of Provexis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Chill Brands Group has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Provexis' return on equity of -68.68% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chill Brands GroupN/A -2,802.21% -44.64%
Provexis -73.10%-68.68%-56.14%

Provexis has higher revenue and earnings than Chill Brands Group. Provexis is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chill Brands Group£624.19K0.00-£3.64M-£0.01N/A
Provexis£846.98K19.56-£619.15K-£0.03-26.77

Chill Brands Group has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Provexis has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.

In the previous week, Chill Brands Group's average media sentiment score of 0.00 equaled Provexis'average media sentiment score.

Company Overall Sentiment
Chill Brands Group Neutral
Provexis Neutral

Summary

Provexis beats Chill Brands Group on 6 of the 10 factors compared between the two stocks.

Get Chill Brands Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHLL and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHLL vs. The Competition

MetricChill Brands GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£8.38M£2.26B£5.81B£3.22B
Dividend YieldN/A2.92%4.39%5.04%
P/E Ratio-165.504.3631.36164.70
Price / SalesN/A691.66387.87310,111.42
Price / Cash11.5010.3738.0227.93
Price / BookN/A11.959.535.91
Net Income-£3.64M£20.70B£3.26B£5.89B
7 Day Performance12.36%1.15%2.14%49.51%
1 Month PerformanceN/A3.95%3.22%56.91%
1 Year PerformanceN/A4.42%30.18%140.38%

Chill Brands Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHLL
Chill Brands Group
N/AN/AN/AN/A£8.38M£624.19K-165.507
PXS
Provexis
N/AGBX 0.71
-4.3%
N/A+39.8%£16.57M£846.98K-26.774Gap Up
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255News Coverage
Gap Up
RGT
Argent BioPharma
N/AN/AN/AN/A£8.31MN/A-0.65N/AGap Down
High Trading Volume
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat
N/AN/A£8.22M£123.38K-1.682,780
N4P
N4 Pharma
N/AGBX 0.40
-18.4%
N/A-9.3%£1.72M£8.84K-1.165Gap Up
HELD
Hellenic Dynamics
N/AGBX 0.01
flat
N/AN/A£14KN/A0.00N/A
BXP
Beximco Pharmaceuticals
N/AGBX 48.40
+1.9%
N/A+65.4%£32.99B£7.08T5.195,500Gap Down
HLN
Haleon
0.9187 of 5 stars
GBX 360.25
+0.3%
GBX 435
+20.7%
-1.8%£32.51B£11.07B30.3025,408High Trading Volume
HIK
Hikma Pharmaceuticals
4.2306 of 5 stars
GBX 1,805
-0.3%
GBX 2,627.50
+45.6%
-8.8%£5.01B£3.74B17.719,100News Coverage
Insider Trade
HCM
HUTCHMED
N/AGBX 237.70
+1.4%
N/A-9.1%£2.58B£771.01M-60.671,760News Coverage

Related Companies and Tools


This page (LON:CHLL) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners